The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

Our Fool likes the look of these stock market juggernauts for the chunky passive income they throw off, not to mention their ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

Bone and Joint Health Supplement Market According to the Future Market Insights’ latest report, global sales of bone and ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

GSK(LSE:GSK) is navigating a dynamic environment marked by both opportunities and challenges. Recent highlights include a ...

Two of the simplest ways to measure the success of companies that develop and commercialize drugs is to count their approvals ...

It was a busy week for the biotech sector, with a lot of important data readouts and regulatory updates. Among these, Terns Pharmaceuticals TERN and Summit Therapeutics SMMT surged after reporting ...